Exposure to Air Pollution Linked to Severe SARS-CoV-2 Outcomes
FRIDAY, May 27, 2022 (HealthDay News) -- Chronic exposure to air pollution, especially ground-level ozone (O3), may contribute to severe outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online May 24 in CMAJ, the journal of the Canadian Medical Association.
Chen Chen, Ph.D., from the University of California San Diego in La Jolla, and colleagues explored long-term exposure to ambient air pollution as a potential contributor to COVID-19 severity in a cohort of all people with confirmed SARS-CoV-2 infection aged 20 years and older. The association of long-term exposure to fine particulate matter (PM2.5), nitrogen dioxide (NO2), and O3 with the risk for COVID-19-related admission, intensive care unit (ICU) admission, and death was examined.
The researchers observed 8,630 hospital admissions, 1,912 ICU admissions, and 2,137 deaths related to COVID-19 among 151,105 people with confirmed SARS-CoV-2 infection in Ontario in 2020. The estimated odds ratios (95 percent confidence intervals) were 1.06 (1.01 to 1.12), 1.09 (0.98 to 1.21), and 1.00 (0.90 to 1.11) for hospital admission, ICU admission, and death, respectively, for each interquartile range increase in exposure to PM2.5. Smaller estimates were seen for NO2. For each interquartile range increase of 5.14 ppb in O3, the corresponding odds ratios (95 percent confidence intervals) were estimated at 1.15 (1.06 to 1.23), 1.30 (1.12 to 1.50), and 1.18 (1.02 to 1.36).
"Uncertainty still remains in the mechanisms of how long-term air pollution might affect COVID-19 severity, which calls for future research," the authors write.
Related Posts
Los 10 síntomas de Alzheimer que debe conocer
MIÉRCOLES, 14 de junio de 2023 (HealthDay News) -- La enfermedad de Alzheimer,...
RSV Prefusion F Protein-Based Immunization Studied in Pregnancy
WEDNESDAY, April 27, 2022 (HealthDay News) -- A bivalent respiratory syncytial...
Health Highlights, Nov. 10, 2021
Pfizer seeks FDA OK of COVID booster shots for all adults. The request was filed...
Cancer of the Appendix: Very Rare, But Genes May Play Role
MONDAY, Nov. 14, 2022 (HealthDay News) -- While appendix cancer is rare, for a...